RENTON, Wash. , Oct. 12, 2022 /PRNewswire/ -- Reducing hospital acquired infections (HAI) is a top priority for all healthcare organizations in the US and other countries. COVID-19 pandemic has further elevated its importance. Two (2) areas of high HAI are in the patient rooms and the patient exam rooms. The patient rooms see medical staff and non-medical staff (housekeeping) as well as patient's guests. The patient exam rooms are regularly visited by patients, medical staff, non-medical staff (housekeeping) and caregivers. Proper disinfection is required in both these areas. Aleddra's EzUVC™ Overbed Light is an effective, affordable and safe product to assist in reducing HAI transmission in both of these areas.

Aleddra, a Seattle -based lighting technology company, is excited to introduce its award-winning 2-in-1 EzUVC™ Overbed Light. It is designed for patient room and patient exam room as an effective, affordable and safe surface disinfection solution. The fixture has (2) operating modes: the regular lighting mode and the UVC germicidal lighting mode. Below are the features of this 2-in-1 fixture:

With Aleddra's 2-in-1 EzUVC™ Overbed Light a non-medical (housekeeping) can simply press the UV On/Off switch, leave the room while the (5) minute or (10) minute disinfection of the patient's bed, pillow, and is taking place or the area in the patient exam room. There is zero labor involved for such surface disinfection, resulting in both labor and material savings and the motion sensor, siren and blinking indicator protect the patients, guests, and medical and non-medical staff from UVC exposure.

For product demonstration, visit: https://www.youtube.com/watch?v=KU8cN0Ca7Ic For product information, visit: https://www.aleddra.com/ezuvc-overbed-light For distribution sales, please contact Aleddra at info@aleddra.com or 425-430-4555.

Media Contact: Matthew Maa 4254304555 346341@email4pr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/aleddra-introduces-2-in-1-ezuvctm-overbed-light-301645629.html

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.